Confirmation on the Immunogenicity Assay Used in the SB4 Phase III Study: Response to the Comments by Meacciet Al
Annals of the Rheumatic Diseases - United Kingdom
doi 10.1136/annrheumdis-2016-209696
Full Text
Open PDFAbstract
Available in full text
Date
May 17, 2016
Authors
Publisher
BMJ